Literature DB >> 17520349

Providing a community-based cancer risk assessment service for a socially and ethnically diverse population.

C Jacobs1, R Rawson, C Campion, C Caulfield, J Heath, C Burton, F Kavalier.   

Abstract

BACKGROUND: Patients from ethnic minorities are under-represented in referrals to cancer genetics services. In a regional genetics centre that serves two London boroughs, the existing service attracts 3% of its referrals from Black and Minority Ethnic (BME) and other ethnic groups, despite the fact that these groups make up 34% of the population.
OBJECTIVES: To improve access to familial cancer risk assessment in a socially and ethnically diverse population.
SETTING: The London boroughs of Lambeth and Southwark.
DESIGN: Community-based, nurse-led clinics were established for people who were concerned about their familial cancer risk. Patients were asked to triage themselves by answering three questions. Self-referral was encouraged. MAIN OUTCOME MEASURES: Data were gathered on ethnicity of clients, cancer risk, source of referral and patient and health professional satisfaction with the service.
RESULTS: Of the 415 people who have accessed the service, 46% were from not White British groups and 67% referred themselves to the service, demonstrating the success of this model in reaching 'hard to reach' groups. Thirty-seven percent of patients were assessed as being at population risk and 63% were assessed as being at moderate risk or higher, showing that the clinics were meeting an unmet need in the community.

Entities:  

Mesh:

Year:  2007        PMID: 17520349     DOI: 10.1007/s10689-007-9134-z

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  4 in total

1.  Guidance on large bowel surveillance for people with two first degree relatives with colorectal cancer or one first degree relative diagnosed with colorectal cancer under 45 years.

Authors:  M G Dunlop
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

2.  Cultural aspects of cancer genetics: setting a research agenda.

Authors:  B Meiser; M Eisenbruch; K Barlow-Stewart; K Tucker; Z Steel; D Goldstein
Journal:  J Med Genet       Date:  2001-07       Impact factor: 6.318

3.  Risk and presenting features of prostate cancer amongst African-Caribbean, South Asian and European men in North-east London.

Authors:  Frank Chinegwundoh; Mohamed Enver; Angela Lee; Vinod Nargund; Tim Oliver; Yoav Ben-Shlomo
Journal:  BJU Int       Date:  2006-12       Impact factor: 5.588

4.  Guidance on gastrointestinal surveillance for hereditary non-polyposis colorectal cancer, familial adenomatous polypolis, juvenile polyposis, and Peutz-Jeghers syndrome.

Authors:  M G Dunlop
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

  4 in total
  4 in total

Review 1.  Disparities in gynecologic cancer genetics evaluation.

Authors:  Emily M Hinchcliff; Erica M Bednar; Karen H Lu; J Alejandro Rauh-Hain
Journal:  Gynecol Oncol       Date:  2019-01-31       Impact factor: 5.482

2.  Could triaging family history of cancer during palliative care enable earlier genetic counseling intervention?

Authors:  Neeta S Lakhani; Jamie Weir; Anna Allford; Joe Kai; Julian G Barwell
Journal:  J Palliat Med       Date:  2013-09-24       Impact factor: 2.947

3.  What hinders minority ethnic access to cancer genetics services and what may help?

Authors:  Anna Allford; Nadeem Qureshi; Julian Barwell; Celine Lewis; Joe Kai
Journal:  Eur J Hum Genet       Date:  2013-11-20       Impact factor: 4.246

4.  Uptake of breast cancer preventive therapy in the UK: results from a multicentre prospective survey and qualitative interviews.

Authors:  Julia Hackett; Rachael Thorneloe; Lucy Side; Michael Wolf; Rob Horne; Jack Cuzick; Samuel G Smith
Journal:  Breast Cancer Res Treat       Date:  2018-04-24       Impact factor: 4.872

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.